

Author: Martin Matthew W Machacek Michelle R
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.20, Iss.11, 2010-11, pp. : 1573-1593
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content










Xanthine oxidase inhibitors: a patent survey
By Kumar Raj Sharma Sahil Singh Rajveer
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 7, 2011-07 ,pp. :